India, Aug. 29 -- The Virtual Investor "Why Now" On-Demand Conference, hosted by Virtual Investor Co. in partnership with JTC Team, wrapped up on August 27, 2026. The program is designed to give investors and analysts direct access to management teams, each presenting why now is the right time for their company's story. The on-demand format emphasizes transparency and accessibility, allowing investors to view presentations at their convenience.
This edition featured a roster of innovative healthcare and biotech companies, including AIM ImmunoTech, Akari Therapeutics Plc, CNS Pharmaceuticals, Dare Bioscience, Inc. enVVeno Medical Corporation, Ernexa Therapeutics, GRI Bio Inc, Moleculin Biotech Inc, Outlook Therapeutics.
For comments and fe...